1964•ScienceRequires access

Skin Tumorigenesis by 7,12-Dimethylbenz( a )anthracene: Inhibition by Actinomycin D

Harry V. Gelboin, Michael Klein

Open publisher page 26 citations

Abstract

Topical application of actinomycin D during a short period of time immediately before and after a single application of 7, 12-dimethyl-benz (a)anthracene markedly inhibits subsequent tumor formation. The results indicate that the initial events of carcinogenesis are dependent on DNA-dependent RNA synthesis.

About this research paper

What this paper is about

Topical application of actinomycin D during a short period of time immediately before and after a single application of 7, 12-dimethyl-benz (a)anthracene markedly inhibits subsequent tumor formation. The results indicate that the initial events of carcinogenesis are dependent on DNA-dependent RNA synthesis.

Why it matters

OpenAlex reports 26 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Topical application of actinomycin D during a short period of time immediately before and after a single application of 7, 12-dimethyl-benz (a)anthracene markedly inhibits subsequent tumor formation. The results indicate that the initial events of carcinogenesis are dependent on DNA-dependent RNA synthesis.

Key concepts: 7,12-Dimethylbenz[a]anthracene, Anthracene, Carcinogenesis, DNA, RNA, Chemistry, DNA synthesis, DMBA

Related papers

Back to paper searchBrowse research topicsOriginal source
Skin Tumorigenesis by 7,12-Dimethylbenz( a )anthracene: Inhibition by Actinomycin D — Research Paper | ScholarLens